key: cord-0838549-vkidjrcq
authors: Jiang, Hong; Cheng, Hongbin; Cao, Qing; Fei, Anxing; Yuan, Ming; Zhang, Lixia; Fei, Shinuan; Li, Jun; Yang, Shixiong; Wu, Jiang; Fu, Qihua; Li, Sheng; Zhang, Xiaoqing
title: Clinical features, laboratory findings and persistence of virus in 10 children with coronavirus disease 2019 (COVID-19)
date: 2020-10-24
journal: Biomed J
DOI: 10.1016/j.bj.2020.10.007
sha: 37b04e12494f10ea6d170c96497a7fae6df04f71
doc_id: 838549
cord_uid: vkidjrcq

BACKGROUND: A pandemic caused by SARS-CoV-2 infection (COVID-19) has rapidly spread across the globe. Although many articles have established the clinical characteristics of adult COVID-19 patients so far, limited data are available for children. The aim of this study was to reveal the clinical features, laboratory findings and nucleic acid test results of ten pediatric cases. MATERIAL AND METHODS: In this retrospective single-center cohort study, pediatric cases with COVID-19 infection were consecutively enrolled in one hospital in Huangshi, China from January 1 to March 11, 2020. RESULTS: A total of 10 children with COVID-19 were recruited. Of them, four were the asymptomatic type, one was the mild type, and five were the moderate type (including two subclinical ones). All patients were from family clusters. Only fever, nasal discharge and nasal congestion were observed. Lymphopenia and leukopenia were uncommon in our sample but elevated levels of lactate dehydrogenase (LDH) and alpha-hydroxybutyrate dehydrogenase (α-HBDH) were observed frequently. Of these laboratory test variables, no statistical difference was identified between asymptomatic and symptomatic patients. Abnormalities in radiological data were detected in five patients, and representative findings of chest CT images were patchy shadows and ground-glass opacities. There were two cases whose oropharyngeal nucleic acid tests reversed to positive after one negative result, and two patients whose oropharyngeal swabs tested negative but rectal swabs showed positive. CONCLUSIONS: Clinical symptoms were mild in children with COVID-19. Increased levels of LDH and α-HBDH were potential clinical biomarkers for pediatric cases. More attention should be paid to the SARS-CoV-2 viral assessment of rectal swabs before patients are discharged.

Since the first case reported in December 2019, a pandemic caused by the novel coronavirus (SARS-CoV-2) infection has been rapidly spreading [1, 2] . Although

China launched an emergency response early in the outbreak, the pandemic has spread around the world, with numerous countries reporting local cycles of transmission [3] . a Public Health Emergency of International Concern, but the number of infected patients is still increasing globally [5] . How to control the spread of COVID-19 has become a global problem. While many articles have established the clinical features of COVID-19 so far, most reports are about adults. However, it is now believed that people at all ages are generally susceptible to SARS-CoV-2, suggesting that it is equally important to understand the clinical features of pediatric patients of COVID-19 [6] . Data on COVID-19 infected children are limited, and studies focusing on the laboratory J o u r n a l P r e -p r o o f abnormalities and nucleic acid tests of pediatric patients are even fewer. In this report, we recruited 10 children with confirmed COVID-19 who were admitted to Huangshi Maternity and Children's Health Hospital in Hubei province, in order to delineate the clinical characteristics, laboratory findings and nucleic acid tests for COVID-19 pediatric cases.

In this retrospective single-center cohort study, pediatric cases with COVID-19 in Huangshi Maternity and Children's Health Hospital of Edong Healthcare Group were consecutively enrolled from January 1 to March 11, 2020 . Data collection forms were generated to collect patients' general information, epidemiological history, clinical manifestations, laboratory examinations, imaging features and treatment. The study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Ethics Committee of Huangshi Maternity and Children's Health

Oropharyngeal swabs, rectal swabs and urine samples of patients were used to test for SARS-CoV-2 using the qRT-PCR kit (Sansure Biotech, Hunan, China). Patients were identified because of their close contacts with confirmed cases or acute fever with no clear predisposing factors. The viral nucleic acid detections were performed following the laboratory guidelines by the Chinese Center for Disease Control and Prevention. 

A total of 10 children with COVID-19 were recruited in our study, two of whom were brother and sister (case 1 and case 2). General information, symptoms and imaging results are summarized in Table 1 . Of these patients, 6 were boys and 4 were girls, with an age range of 1.5 months to 120 months (median age = 25 months; mean age = 48 months). One child (case 7) was from Wuhan, and the other nine patients were local residents of Huangshi city (an epidemic region 100 kilometers away from Wuhan). Case 8 was the youngest patient in Huangshi, diagnosed at 44 days after birth. All these children had close contact with adult family members with laboratory-confirmed SARS-CoV-2 infection. No history of underlying diseases was declared among these patients.

At illness onset, four children (case 7, case 8, case 9, and case 10) had fever, with peak body temperatures varying from 37.5℃ to 38.7℃. None of them developed high fever (body temperature above 39℃). Case 7 and case 9 presented nasal discharge and nasal congestion. No other symptoms frequently observed in adult patients, such as fatigue and myalgia, were found in these cases, and none of them developed dyspnea [9] [10] [11] . The remaining six children had no clinical symptoms at all and were diagnosed because of their household exposure to COVID-19.

Upon admission, abnormalities in radiological data were detected in five patients.

Three of them (case 5, case 8 and case 9) had bilateral involvement, and the other two patients (case 6 and case 10) had abnormalities on only one side of their lungs.

Representative findings of chest CT images were patchy shadows and ground-glass opacities. CT scans of the remaining five patients showed normal results.

Of the ten patients, four were classified as the asymptomatic type (case 1, case 2, case 3 and case 4) with normal clinical phenotypes and chest imaging results. One patient was classified as the mild type (case 7), showing symptoms but no signs of pneumonia based on chest imaging. The remaining five patients were considered as moderate type, showing abnormal chest imaging results and/or clinical symptoms.

Children with the moderate type included two subclinical patients (case 5 and case 6), who had no clinical symptoms but had chest CT results that showed pulmonary lesions.

For all patients, oropharyngeal swab specimens were detected for SARS-CoV-2 on their admission and during their hospitalization period. The duration of virus shedding in respiratory specimens, which is the interval from the first day of either symptom onset (symptomatic patients) or positive SARS-CoV-2 detection tests (asymptomatic patients) to the first day of two consecutive negative results, ranged from 7 days to 16 days after illness onset. The time of virus shedding in respiratory was longer in symptomatic patients than asymptomatic ones (p=0.019). Of particular concern, two patients (case 2 and case 6) had oropharyngeal nucleic acid test reversed to positive after one negative result. Nucleic acid detection results of the 10 pediatric patients are shown in Figure 1 . Positive results of rectal swabs were observed in case 1, case 2, case 3, case 5, case 6 and case 8 on the 3 rd , 3 rd , 4 th , 12 th , 10 th and 15 th day since their illness onset, respectively. Interestingly, case 5 and case 8 tested positive on rectal swabs on the 12 th and 15 th day, but their oropharyngeal swabs showed negative.

Of the nine children who received routine blood test upon admission (case 4 did not receive any tests during hospitalization other than COVID-19 testing), the majority Table 2 .

All patients received antiviral therapy with α-interferon together with arbidol hydrochloride granules, oseltamivir phosphate, cetirizine hydrochloride, or lopinavir and ritonavir tablets. The duration of antiviral treatment ranged from 6 to 16 days.

Empirical antibiotic (ceftezole sodium or amoxicilli flucloxicillin sodium) treatment were performed on four symptomatic cases. Additionally, traditional Chinese medicine including Lianhua Qingwen capsule and Xiaoerchiqiaoqingre granule were prescribed to two children. None of the patients needed invasive respiratory support or extracorporeal membrane oxygenation. As of March 11, 2020, all the patients had been discharged after hospitalization for a median of 12 days (ranged from 7 to 17 days).

Genetic analysis of SARS-CoV-2 has revealed that the virus is a beta-coronavirus that belongs to the family coronavirus within the order Nidovirales [11] . Coronaviruses mainly infect the respiratory tract and cause respiratory syndromes in humans, such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS)

and COVID-19 [12, 13] , all of which are newly emerged infectious diseases that pose a great threat to international public health.

In the present study, we provided clinical and laboratory data of 10 pediatric J o u r n a l P r e -p r o o f

province. Of them, four were classified as the asymptomatic type, one was the mild type, and five were the moderate type (including two subclinical cases). All patients in our study were infected through intrafamily transmission. Fever, nasal discharge and nasal congestion were the only symptoms observed upon their admission. All patients had a good prognosis and was discharged within 1 to 3 weeks after illness onset.

These findings suggest that clinical symptoms tend to be mild among children with COVID-19, which is consistent with previous reports, which show that the frequency of confirmed severe and critical cases in children with COVID-19 is significantly lower (3%) compared with the overall frequency (18%) in all infected cases [8, 14] .

Similarly, during the outbreak of SARS and MERS, the numbers of overall pediatric cases and severe pediatric cases were far lower than those of adult cases; no fatal pediatric cases were reported [15] .

Existing reports suggest that laboratory abnormalities frequently observed in COVID-19 patients include elevated white blood cell count, neutrophil count, alanine aminotransferase, LDH, D-dimer, PCT and deranged albumin, and lymphocyte count [16] . These abnormalities tend to be much more prominent in severe or critical adult patients [2, 17] , indicating their potential role in the assessment of disease severity.

However, it remains unclear whether these abnormalities are also applicable to pediatric cases, whose phenotypes tend to be milder. In our report on pediatric cases, few cases with lymphopenia and leukopenia were detected. In contrast, increased lymphocyte count was observed in five patients. Considering that the proportion and J o u r n a l P r e -p r o o f absolute count of lymphocyte in children are typically higher than adults, the significance of this index needs to be verified by a larger sample [18] . On the other hand, increased levels of serum CRP and ESR, which indicate inflammatory response, were observed in patients with symptoms, radiological changes, or a combination of both. However, no statistical difference in these laboratory test results was identified between asymptomatic and symptomatic patients.

It is worth noting that levels of LDH and α-HBDH were increased in six out of eight patients in our study, regardless of whether clinical symptoms were present. Similar findings emerged from the article published by Hu, et al. [19] who demonstrated that lymphopenia, leukopenia and other abnormal laboratory findings were uncommon in asymptomatic cases, but relatively more cases (29%, 7/24) presented an elevated level of serum LDH. Zhao et al. [20] compared the abnormal laboratory tests between COVID-19 patients and other pneumonia patients and found that levels of LDH and α-HBDH were abnormal in a larger proportion of COVID-19 patients. Du et al. [21] enrolled 53 adult and 14 children cases with COVID-19 and found that the value and positive rate of LDH in children were more significantly increased than in adults (p = 0.01; p = 0.02). Additionally, Stockman et al. [15] demonstrated that an elevated level of LDH is one of the most common biochemical abnormalities in children with SARS.

Our study further suggests that LDH and α-HBDH could be potential indicators of COVID-19 in pediatric cases.;

LDH is a ubiquitously expressed enzyme that catalyzes the interconversion of pyruvic acid and lactic acid; LDH is composed of five isozymes (LDH1-5) [22] [23] . α-HBDH J o u r n a l P r e -p r o o f has been considered to be an indirect reflection of LDH1 and LDH2 activity and is mainly found in heart muscle and red blood cells [24] . Considering that heart abnormalities are relatively common among patients with COVID-19 [25] , elevations of serum LDH and α-HBDH in our report might be a reflection of cardiomyocyte damages. However, since abnormal LDH and α-HBDH have also been reported in other organ dysfunction [26] , their practical clinical significance in COVID-19

requires further investigation.

Standards (Seventh Edition) published by the National Health Committee, SARS-CoV-2 test results in respiratory samples were used as criteria for diagnosis and discharge. In our report, oropharyngeal swabs were examined for all patients, and two consecutive negative nucleic test results indicated that the patient could be discharged. The results of two patients are of particular note, as their oropharyngeal swabs tested negative but rectal swabs tested positive. One of the two patients even met the criteria of inpatient discharge despite testing positive on the rectal swab, which challenges the current guidelines for discharging COVID-19 patients. Similar results were shown by Cai et al. [27] , who found that SARS-CoV-2 was detected in feces at a high frequency, and Xu et al. [28] , whose viral RNA measurements suggested that viruses in feces might be greater in number and longer-lasting than those from the respiratory tract. Evidence has mounted of the transmission of SARS-CoV-2 through the digestive tract, and discharged patients may shed virus through defecation for a long time [29] . Chan and his colleagues performed studies on J o u r n a l P r e -p r o o f SARS-CoV shedding pattern and the diagnostic yield of various specimen types [30] .

They found that stool or rectal swab specimens provided the highest positive virologic rate and a prolonged viral shedding period. Compared with rectal sampling, another limitation of oropharyngeal sampling for COVID-19 patients is that the relatively invasive collection procedure of oropharyngeal swabs is uncomfortable and can induce coughing and sneezing. This will generate infectious aerosols and increase the risk of medical staff's exposure to virus. Non-standardized sampling procedure may lead to false negative results, especially for young children [31] . Therefore, both prolonged presence of SARS-CoV-2 in feces and potential false negative of the oropharyngeal sample might lead to the observed discrepancies in nucleic test results for rectal versus oropharyngeal swabs in our study. Considering the emergence of discharged patients of return positive nowadays, criteria for hospital discharge and methods for sampling should be reassessed [32, 33] 

Even though children infected with SARS-CoV-2 tend to have mild symptoms or no symptoms at all, they can still release viruses. Until now, there is no unified treatment or specific vaccination available for COVID-19, so early identification, timely diagnosis and intense surveillance are vital. Our study suggests that increased levels of serum LDH and α-HBDH are potential clinically useful biomarkers for pediatric cases, and more attention should be paid to the SARS-CoV-2 viral assessment of rectal swabs before patients are discharged.

We thank all the patients for their participation in this study.

This work was supported by the Shanghai Sailing Program (Grant numbers 18YF1414800).

The authors have no conflict of interest relevant to this article to disclose.

J o u r n a l P r e -p r o o f 

conceptualized and designed the study, collected data, drafted the initial manuscript, and reviewed and revised the manuscript. Q.C and Q.H.F carried out the initial analyses

Early transmission dynamics in Wuhan, China, of novel Coronavirus-infected pneumonia

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

The effect of travel restrictions on the spread of the

World Health Organization. Coronavirus disease (COVID-19) outbreak

SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics

Clinical characteristics of coronavirus disease 2019 in China

Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China

SARS and other coronaviruses as causes of pneumonia

Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China

Severe acute respiratory syndrome in children

Laboratory abnormalities in patients with COVID-2019 infection

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan

Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China

Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing

A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias

Clinical characteristics of COVID-19 in children compared with adults in Shandong Province

Regulation of pyruvate metabolism and human disease

Elevated level of serum LDH2 and LDH3 in sputum three positive TB patients of Sahariya tribe: a preliminary study

Alpha-hydroxybutyrate dehydrogenase as a biomarker for predicting systemic lupus erythematosus with liver injury

Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China

Serum lactate dehydrogenase and survival following cancer diagnosis

A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features

SARS-CoV-2 infection and potential evidence for persistent fecal viral sheddding

Public health might be endangered by possible prolonged discharge of SARS-CoV-2 in stool

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standard for discharge

False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence

Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019